Is Big Pharma's Next Target Already in Play?
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
| Open | 46.74 | Prev Close | 47.10 |
| High | 46.83 | Low | 46.38 |
| Volume | 2,970,033 | Volume (Avg) | 4,908 |
| 52 Week High | 47.21 | 52 Week Low | 30.68 |
| Market Cap | 93.6B | PE Ratio | 13.28 |
General
| Name | GSK Plc ADR |
| Ticker | GSK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 68,629 |
About GSK Plc ADR
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.
Highlights
| Analyst Target | 47.53 |
| Market Cap | 93,574,700,000 |
| PE Ratio | 13.28 |
| PEG Ratio | 0.38 |
| EBITDA | 9,518,999,552 |
Valuation
| Trailing PE | 13.61 |
| Forward PE | 8.44 |
| Price/Sales (Trailing 12 Mt.) | 2.94 |
| Price/Book (Most Recent Quarter) | 4.42 |
Technicals
| Beta | 0.47 |
| 52 Week High | 47.21 |
| 52 Week Low | 30.68 |
| 50 Day Average | 8.81% |
| 200 Day Average | 18.65% |
Dividend
GSK Plc ADR pays out a dividend of $1.72 per share, with a dividend yield of 3.68%.
GSK's next dividend payment will be made to shareholders on January 8, 2026.
They pay out 94.89% of their earnings out as a dividend.
Recent Dividends
| Jan 8, 2026 | $0.41 |
| Oct 9, 2025 | $0.43 |
| Jul 10, 2025 | $0.43 |
| Apr 10, 2025 | $0.40 |
| Jan 9, 2025 | $0.39 |
| Oct 10, 2024 | $0.39 |
| Jul 11, 2024 | $0.38 |
| Apr 11, 2024 | $0.41 |
| Jan 11, 2024 | $0.34 |
Trump administration moves to loosen restrictions it once supported on a harmful pollutant
WASHINGTON (AP) — Near the end of his first term, President Donald Trump signed into law a bill that and air conditioners. The bipartisan measure brought environmentalists and major business groups into rare alignment on the contentious issue of climate change and won praise across the political spectrum.
Indians who fled a Myanmar cyberscam center are being flown home from Thailand
MAE SOT, Thailand (AP) — is repatriating on Thursday the first batch of hundreds of its nationals who last month fled to Thailand from Myanmar, where most had been working at a .
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Democrats win big over GOP incumbents in 2 statewide Georgia utility regulator races
ATLANTA (AP) — Two Democrats romped to wins over Republican incumbents in elections to the on Tuesday, delivering the largest statewide margins of victory by Democrats in more than 20 years.
IRS Direct File won't be available next year. Here's what that means for taxpayers
WASHINGTON (AP) — IRS Direct File, the electronic system for filing tax returns for free, will not be offered next year, the Trump administration has confirmed.
Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad
You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1
Embed-Graphic-Musk-Pay Package-Explainer, ADVISORY
MUSK-PAY PACKAGE-EXPLAINER — Graphic. Elon Musk turned off potential buyers of his Tesla cars and sent sales plunging by spouting off about politics, but he says the company can’t do without him and should pay him more — a lot more. The following digital embed shows the milestones required for Elon Musk to receive a desired $1 trillion pay package from Tesla. This graphic is current as of Nov. 4, 2025 and will not update. Source: Tesla; FactSet
Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It
November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Hedera Gets Its First ETF: Canary's HBAR Fund Lets Investors Tap Into The Tokenization Boom
Canary Capital Group’s new fund, the Canary HBAR ETF (NASDAQ:HBR), launched on Oct 28, marking a significant expansion of investors’ access to digital assets outside of Bitcoin and Ethereum.
Trump's White House Bathroom Renovation Sparks Fury, Economist Slams 'Clearly Wrong' Inflation Data And More: This Week In Economy
Week economy roundup: From inflation debates and White House renovations to job declines, stock surges, and Fed rate cuts.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Trump may become the face of economic discontent, a year after such worries helped him win big
WASHINGTON (AP) — President got a serious that he’s out of touch with their fears about a deteriorating U.S. economy.
Cathie Wood Makes $13.4 Million Bet On This Social Network After Earnings Crash — But Dumps Robinhood And Reddit
Ark Invest made significant trades, focusing on Pinterest, Robinhood, and Reddit amid earnings reports. They have confidence in Pinterest's potential despite recent setbacks.
Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
Shaquille O'Neal's $180,000 Range Rover Stolen in Suspected Hacker Heist
The custom Range Rover belonging to Shaquille O'Neal has been stolen, reportedly due to a cyber attack.
Warren Buffett Opens Up About The Biggest Investing Blunders Of His Career — Here They Are
Over the decades, the "Oracle of Omaha" has shared candid reflections on his biggest blunders, from emotional decisions to missed opportunities, all of which provide timeless investing insights.
Nvidia CEO: E.I. Will Be as Common as Cars Today - Ad
E.I. isn't science fiction anymore. It's already here. And one little-known company is quietly supplying the systems behind it. This stock is still under Wall Street's radar... but not for long. You'll get the name, the ticker, and the full thesis inside.
Elon Musk Tells Joe Rogan: 'Trump Actually Is Not Perfect, but He's Not Evil'
In a Friday appearance on The Joe Rogan Podcast, Elon Musk defended President Donald Trump, stating that while Trump is "not perfect," he is also "not evil."
Trump Says Biden Was 'Vicious On Crypto' But He's Ended The 'War' On The Industry: 'It Was Terrible'
President Donald Trump reiterated his support for the cryptocurrency industry on Wednesday, adding that the asset class takes significant pressure off the dollar.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
AMD, Super Micro Computer, Upstart Holdings, Pinterest And Rivian: Why These 5 Stocks Are On Investors' Radars Today
AMD, SMCI, UPST, PINS, RIVN were among the stocks seen trending on Tuesday, Nov. 4, 2025.
Sawyer Merritt Threatens To Move Assets If Charles Schwab Votes Against Elon Musk's Tesla Pay Package: 'I Can't In Good Conscience...'
Sawyer Merritt criticizes Charles Schwab for voting against Musk's $1 trillion pay package, threatening to move assets.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
Coeur Mining's $7 Billion Deal For New Gold Creates $20 Billion Powerhouse
Coeur Mining Inc. (CDE) announced acquisition of New Gold Inc. (NGD) in all-stock deal valued at $7 billion.
Tempus AI Stock (TEM) Slides 6% Overnight: Here's Why The Stock Is Trending
Tempus AI shares fell 6.02% in after-hours trading Tuesday following its third-quarter earnings report.
On November 18, a powerful new law signed by President Trump will trigger a radical shift in America's money system... - Ad
When a small group of private companies - not the Fed - will perform a major mint of a new kind of money. And those who act before this new system fully kicks in could see gains as high as 40X by 2032. But those who fail to prepare will be blindsided by this sea change to the U.S. dollar.
Shutdown stalemate set to drag into sixth week as Trump pushes Republicans to change Senate rules
WASHINGTON (AP) — Republicans and Democrats remained at a stalemate on the over the weekend as it headed into its sixth week, with for millions of Americans and President Donald Trump pushing GOP leaders to change Senate rules to end it.
Can Solana Do What Bitcoin Can't? Amplify's New ETF Aims For 36% Income
Amplify ETFs, the issuer known for thematic and income-driven fund products, has just launched the Amplify Solana 3% Monthly Option Income ETF (BATS:SOLM), a first-of-its-kind product combining the growth momentum in Solana (CRYPTO:
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
San Francisco mayor proposes denser housing to tackle affordability crisis
SAN FRANCISCO (AP) — San Francisco Mayor Daniel Lurie is trying to get more homes built for people like Liam Murphy: a fifth-generation city kid who found himself repeatedly outbid for tiny two-bedroom houses that wound up selling for $1.6 million.
Sam Altman Says 'Shame on Me' If OpenAI Doesn't Become 'First Big Company' Run By An AI CEO
Sam Altman, the CEO of OpenAI, has made a bold prediction about the future of the company.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Why Is Phio Pharmaceuticals Stock Soaring Today?
Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) are rising Monday after the company provided an update on an ongoing medical trial.
Elon Musk Calls Out Sam Altman Over Tesla Roadster Refund: 'This Issue Was Fixed and You Received a Refund Within 24 Hours'
Elon Musk and Sam Altman are once again in a public spat, this time over a car.
Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad
You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading?
MediciNova shares soared over 87% in after-hours trading on Thursday following the publication of promising research.
Nigerian billionaire plans expansion of Africa's biggest oil refinery
ABUJA, Nigeria (AP) — The billionaire owner of plans to expand its capacity to 1.4 million barrels per day to meet growing fuel needs in the continent and beyond.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Trump's $8.5 Billion Deal With Australia Challenges Chinese Dominance
Trump and Albanese signed a partnership to secure critical mineral supply chains and strengthen defense cooperation.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.